Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

294.67 +11.16 (+3.94%)

Streaming Delayed Price Updated: 3:33 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System

September 20, 2022

From Insulet Corporation

Via Business Wire

Neurocrine Leads 5 Stocks To Watch In Sickly Market ↗

September 03, 2022

Neurocrine Biosciences leads five medical stocks showing resilience.

Via Investor's Business Daily

A Bullish Sign Appears On Insulet's Chart ↗

September 01, 2022

If history is any guide, there may be good fortune ahead for shares of Insulet (NASDAQ:PODD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the...

Via Benzinga

$1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today ↗

August 23, 2022

Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of...

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above ↗

August 22, 2022

Via Benzinga

What 8 Analyst Ratings Have To Say About Insulet ↗

August 05, 2022

Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:

Via Benzinga

Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 ↗

August 22, 2022

Reuters Vodafone To Sell Hungarian Business For $1.8B: Report

Via Benzinga

FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children ↗

August 22, 2022

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with...

Via Benzinga

Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes

August 22, 2022

From Insulet Corporation

Via Business Wire

Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance ↗

August 05, 2022

Via Benzinga

5 Analysts Have This to Say About Insulet ↗

June 24, 2022

Insulet (NASDAQ:PODD) has observed the following analyst ratings within the last quarter:

Via Benzinga

4 Analysts Have This to Say About Insulet ↗

June 07, 2022

Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 05, 2022

From Insulet Corporation

Via Business Wire

Recap: Insulet Q2 Earnings ↗

August 04, 2022

Insulet (NASDAQ:PODD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Insulet missed estimated earnings by...

Via Benzinga

Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)

August 04, 2022

From Insulet Corporation

Via Business Wire

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System

August 01, 2022

From Insulet Corporation

Via Business Wire

The Healthcare Companies Fighting the World’s Biggest Killers

July 13, 2022

Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...

Via FinancialNewsMedia

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 ↗

July 11, 2022

Upgrades

Via Benzinga

Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022

June 30, 2022

From Insulet Corporation

Via Business Wire

7 Stocks to Buy That Could Make You a Millionaire ↗

June 23, 2022

These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments.

Via InvestorPlace

Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close ↗

June 16, 2022

The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness...

Via Benzinga

Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years

June 03, 2022

From Insulet Corporation

Via Business Wire

Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference

June 02, 2022

From Insulet Corporation

Via Business Wire

Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia

June 01, 2022

From Insulet Corporation

Via Business Wire

Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks ↗

May 31, 2022

The deal would have been transformative, but may have limited teamwork in the space.

Via Investor's Business Daily

Looking Into Insulet's Return On Capital Employed ↗

May 26, 2022

According to Benzinga Pro, during Q1, Insulet (NASDAQ:PODD) earned $27.80 million, a 4.79% increase from the preceding quarter. Insulet's sales decreased to $295.40 million, a 4.0% change since Q4.

Via Benzinga

How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space ↗

May 24, 2022

One analyst called the rumored deal "transformative," but says the timing is unfavorable.

Via Investor's Business Daily

PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition ↗

May 24, 2022

Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company.

Via InvestorPlace

Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg ↗

May 24, 2022

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.